Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of a simple, minimally invasive Targeted Thermal Therapy (Triple T) that has ...

They were also compared to a control group composed of equal proportions of individuals initiating sulfonylureas, DPP4 inhibitors, and SGLT2 inhibitors (536,068 people), as well as a control group ...

Heart failure with preserved ejection function is a lethal form of heart failure ... Currently, there are only two drugs for HFpEF: SGLT2 inhibitor and ARNI. The ALPK2/TPM1 regulatory axis ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much ...

such as perceived frailty or concern about tolerating a full dose medication,” said Wiviott. No Head-to-Head Studies SGLT2 inhibitors, which were initially approved for glycemic control, have been ...

Opens in a new tab or window Comparative effectiveness study followed adults with type 2 diabetes who initiated SGLT-2 inhibitors from 2014 to 2020. Real-world outcomes largely point to comparable ...

SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission Study provides a practical strategy to achieve remission for adults with type 2 diabetes Peer-Reviewed Publication ...

SSC Full Form: The full form of SSC is Staff Selection Commission. The SSC is a major body of the Department of Personnel and Training (DoPT) and it includes a Chairman, two members, and a ...

SGLT2 inhibitor use might be renoprotective in patients with ADPKD, but could increase kidney volume. Dapagliflozin might help protect kidney function in patients with autosomal dominant polycystic ...